|
Play Video: The Importance of Insider Buying
|
|
|
The table below summarizes the most recent TBIO insider buying information, with links below the price to see the
CAGR achieved by each insider on their purchases. As the saying goes on Wall St., there are many
possible reasons to sell a stock, but only one reason to buy. Watch the importance of insider buying video for more
information about why TBIO insider buys are important for investors to follow.
Date | Insider | Price | Amount |
9-14-2021 Insider Buy |
Sanofi >10% Owner |
$38.00
CAGR »
|
$2,735,376,686.00 71,983,597 shares |
7-2-2018 Insider Buy |
Brian M. Gallagher Jr. Director |
$13.00
CAGR »
|
$3,499,990.00 269,230 shares |
7-2-2018 Insider Buy |
MRL Ventures Fund LLC >10% Owner |
$13.00
CAGR »
|
$325,000.00 25,000 shares |
7-2-2018 Insider Buy |
Plc Glaxosmithkline >10% Owner |
$13.00
CAGR »
|
$3,499,990.00 269,230 shares |
1-6-2016 Insider Buy |
Randal J. Kirk >10% Owner |
$1.00
CAGR »
|
$4,474,825.00 4,474,825 shares |
10-2-2013 Insider Buy |
Leroy C. Kopp >10% Owner |
$0.39
CAGR »
|
$3,510.00 9,000 shares |
Also See: Institutional Holders of TBIO
Also See: SEC filings
Below we present the annualized performance delivered by TBIO stock since 9-14-2021 (the date of the most recent
insider purchase). The performance of the investment from the time TBIO insider buying occurred is the ultimate
test of whether insiders were right about TBIO being a good buy.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
09/15/2021 |
|
End date: |
04/24/2024 |
|
Start price/share: |
$12.77 |
|
End price/share: |
$0.32 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-97.49% |
|
Average Annual Total Return: |
-75.64% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$251.37 |
|
Years: |
2.61 |
|
TBIO Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.),
and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these
categories, but instead file their holdings quarterly on the latest form 13F filings.
While recent TBIO insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding TBIO
|
|